| Authors: |
Broom RJ; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand. Electronic address: ReubenB@adhb.govt.nz., Hinder V; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand., Sharples K; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand; Department of Preventative and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Proctor J; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand., Duffey S; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand., Pollard S; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand., Fong PC; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand., Forgeson G; Midcentral Regional Cancer Treatment Service, Palmerston North Hospital, Palmerston North, New Zealand., Harris DL; Oncology Service, Christchurch Hospital, Christchurch, New Zealand., Jameson MB; Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand., O'Donnell A; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand., North RT; Tauranga Hospital, Tauranga, New Zealand., Deva S; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand., Hanning FJ; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland, New Zealand., Grey A; Department of Medicine, University of Auckland, Auckland, New Zealand., Findlay MP; Cancer Trials New Zealand, Discipline of Oncology, University of Auckland, New Zealand. |
